Global Primary Immunodeficiency Therapeutics Market Share

Statistics for the 2023 & 2024 Global Primary Immunodeficiency Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Global Primary Immunodeficiency Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Primary Immunodeficiency Therapeutics Industry

The primary immunodeficiency therapeutics market is consolidated with the presence of a few major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Baxter International Inc, Takeda Pharmaceutical Company Limited, CSL Ltd, Biotest AG, Octapharma AG, Kedrion Biopharma Inc, Bio Products Laboratory Limited, LFB group, Grifols S.A, and Lupin Pharmaceuticals.

Primary Immunodeficiency Therapeutics Market Leaders

  1. Baxter international Inc

  2. Takeda Pharmaceutical Company Limited

  3. CSL Ltd

  4. Octapharma AG

  5. Biotest AG

*Disclaimer: Major Players sorted in no particular order

Primary Immunodeficiency therapuetics market - cl.png

Primary Immunodeficiency Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)